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a  b s t  r a  c t
The present study aims at shedding light  on the transport mechanisms involved in a  func-
tionalized  membrane designed for  improving hemodialysis. This  membrane is prepared
by  embedding absorptive micro particles within its porous structure. To  understand the
transport  mechanism through the membrane and  make suggestions for  its optimization, a
mathematical model coupling convection, diffusion and adsorption is  developed and vali-
dated  by comparison of experimental and  theoretical results. In fact, the model provides a
description of the concentration profile from the donor (feed) compartment across the sev-
eral  layers with  different properties to the acceptor (dialysate) compartment. In addition,
the  model allows to predict the influence of various parameters such  as molecule diffu-
sivity,  membrane thickness, presence of convection, content of adsorptive particles on the
flux intensification across the membrane. Comparison with experimental measurements
demonstrates that the model is  able to describe the transmembrane mass flux variation over
time as a  function of hydrodynamic conditions and membrane/module geometric param-
eters.  The  model also illustrates how the proposed double-layer membrane concept offers
significant  benefits in terms of toxin removal in comparison to conventional dialysis. As  so,
the main achievement of the developed model is that it  may serve as tool for the further
improvement  of functionalized membrane in terms of toxin removal and optimization of
process conditions.
1. Introduction
Hemodialysis is a  life-sustaining treatment that patients undergo when
their  kidneys malfunction. Even though this technique is constantly
being improved for  more than four decades it  is still one of  the major
healthcare  problems with  high mortality and morbidity of the  patients.
High  mortality rates are usually attributed to  incomplete removal of the
blood  toxins during the  dialysis treatment (Dobre et  al.,  2013;  Meyer
et  al., 2011; Vanholder et  al., 2015). The treatment provides  adequate
removal  of only the  small water  soluble molecules,  such as  urea or
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creatinine. However, larger solutes, referred  to as middle molecules and
the  protein-bound toxins, have inadequate clearance even after the
development of  more permeable high-flux hemodialyzers (Eloot  et al.,
2012;  Luo et  al., 2009).
As this extracorporeal treatment is primary driven by  diffusion,
the  use  of high  volumes of pure  dialysate  liquid is necessary to  maxi-
mize  the concentration gradients across the  membrane (Walther et al.,
2006).  Large volumes of high-quality dialysate solution make such an
approach  not only  expensive, but also challenging for countries with
scarce  water  resources. Besides, it was demonstrated in various studies
http://dx.doi.org/10.1016/j.cherd.2017.08.017
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Nomenclature
a Specific surface area of the adsorbent (m2 per
m3 of mixed matrix membrane)
c Concentration (mol m−3)
d  Diameter (m)
D  Diffusion coefficient (m2 s−1)
div Divergence (–)
j  Molar flux density (mol m−2 s−1)
J  Convective flow through the membrane (m s−1)
k  Heterogenic adsorption constant (m s−1)
K Pseudo mass transfer conductance (m s−1)
l Length of the fiber (m)
m  Mass (kg)
M  Molecular weight (g mol−1)
N Number of fibers (–)
Pe  Peclet number (–)
q  Quantity of adsorbed specie (mg per mg of mem-
brane)
r  Rate of adsorption (mol m−3 s−1)
Re  Reynolds number (–)
s  Sink term (mol m−3 s−1)
S  Membrane surface area (m2)
Sc Schmidt number (–)
Sh  Sherwood number (–)
t  Time (s)
V  Volume of fluid (m3)
Greek letters
ı  Thickness of the domain (m)
1 Determinant defined in  Eq. (5) (–)
f Thiele modulus (–)
Subscripts
0  Initial time point
a  After the adsorptive layer
ads  Adsorption
b Before the adsorptive layer
conv Convection
d Dialysate
diff Diffusion
e  External
f  Feed
h  Hydraulic
in At the inlet of particular domain
l Lumen of the membrane
max  Maximal
out At the outlet of particular domain
s Shell side of the module
t  Time different from 0
(Barreto et al., 2009; Busch  et  al., 2010; Liabeuf et  al., 2011;  Raj et  al., 2000)
that  poor removal of some uremic toxins (i.e. b-2-microglobulin), leads
to  other long-term hemodialysis related complications. Thus, there is
an  urgent need of new improvement of dialysis in order to  overcome
highlighted drawbacks.
A novel specific approach to maintain the beneficial high  gradients
across  the dialysis membrane along  with  facilitated transport of ure-
mic  solutes was discussed by Meyer et  al. (2007). There, addition of
the  sorbent to the dialysate solution resulted in significant increase
of  removal rates of various protein-bound toxins even without high
dialysate flow rates. Such results demonstrated the great  opportunities
of  combining the benefits of adsorption and  filtration. More recently,
some  of  the authors of this  work developed and  proved the concept of
the  double layer mixed matrix membranes (Pavlenko et al., 2016;  Tijink
et  al.,  2013,  2012). These membranes consist of  two layers: (1) a  mixed
matrix  layer, where activated carbon particles are  incorporated inside
a  porous polymer matrix; (2) a particle-free selective layer providing
hemocompatibility and selectivity.  Such design makes it possible to
gain  the benefits of  the  adsorption and  diffusion in one step. In partic-
ular,  membranes in both  flat and hollow fiber double layer geometries
showed  an  excellent removal of small  and protein-bound toxins from
human  plasma giving high promise for their further development for
dialytic  applications.
However,  the contribution of the mixed matrix layer to the  removal
of  the  uremic toxins, as  well  as  the influence of the membrane
characteristics and  process conditions need to be quantified on  an
experimental  and  on a  theoretical point of view. It is for example
important to know how to  optimize  the transfer through a  mixed
matrix membrane. To  tackle this  question, in this  work, we developed
a  model with various parameters and their physical relationships, in
order  to describe the  overall performance of  the  membrane towards
removal  of small  and middle-sized uremic toxins. The objective of this
model  is to offer  an analytical and non-numerical problem resolution
and  to  give  the  opportunity to optimize the  membrane properties and
process  conditions. The upcoming sections are organized in  the  follow-
ing  manner: first, the selected assumptions along with mathematical
derivation of required equations are  described in order to formulate
the  model. Secondly, the fabrication and characterization of  function-
alized  double-layer membranes is presented. Then, the  prediction of
solute  concentration profiles  across  the membrane with  use  of the
model  is  demonstrated. Finally, the  developed model is  validated by
the  comparison with  the experimental results.
2.  Model  development
A  model is presented to describe the coupling of transport
phenomena (advection, diffusion and adsorption) by  describ-
ing  the mixed matrix membranes by composite layers (Section
2.1).  This one dimension model allows determining the con-
centration profile and the mass flux across the membrane and
then  the efficiency improvement due to  the adsorbent (Section
2.2).  In a last Section 2.3, this model for the transfer through
the membrane is combined with the mass flux balances on
the  blood and dialysate side in order to  depict the clearance
variation along dialysis.
2.1.  Mass  balance  in  the layers  composing  the mixed
matrix membrane
The geometry of the system was dictated by the novel concept
of  blood filtration, which employs the membranes functional-
ized  with adsorptive particles (Tijink et al., 2012). In its way
through the membrane, a toxin present in the blood (feed
stream)  first passes through the  particle-free layer (PFL) and
then  through the mixed matrix layer, where it can adsorb on
the  dispersed adsorptive particles as depicted in  Fig. 1. The
effect of the flow parallel to the membrane in the feed (blood)
and  dialysate side are modelled with boundary layers thick-
ness.  At  the end, a  four-layers system (Fig. 1) describe the
mixed matrix membrane.
The  model of solute transport through this system relies
on  following assumptions:
1)  Superficial resistances are  accounted through an  averaged
boundary layer thickness along the Y axis (Fig. 1);
2)  Steady state for the transfer is considered through the
membrane;
Fig. 1 – The schematic representation of the system geometry (dots in the feed represent the toxin molecules present in  the
blood stream). 1 — feed side boundary layer, 2 — particle-free membrane, 3 — mixed matrix membrane, 4 — dialysate
boundary layer.
3)  Cartesian coordinates are used to  describe a planar mem-
branes  or hollow fibers when the boundary layer thickness
are  small compared to the fiber lumen;
4) Fluids in  the blood and dialysate compartments are New-
tonian;
5)  Adsorptive particles are considered to be uniformly dis-
persed  inside the polymeric matrix;
6) Adsorption is considered as first order heterogeneous reac-
tion.  Dealing with the adsorption mechanism, such a
kinetic condition can correspond to the system where the
adsorptive capacity is large  compared to the amount to be
adsorbed.
7)  The transfer inside the adsorptive particles is not diffusion-
limited.  The particles are small enough to avoid a diffusion-
controlled adsorption inside the particles.
8) The solute is considered small enough for its rejection by
the  membrane can be considered to be zero. Hence, the  par-
tition  coefficient is then taken equal to one. In the case of
future  applications in which the solute would not be small
compared to the pore size, the model could be easily mod-
ified  to integrate a partition coefficient between the bulk
and  the membrane in order to take into account the effect
of  pore on the selectivity.
The  mass transport of solute across the membrane is  con-
ventionally described by the generic continuity equation in
the  form of Eq. (1):
∂c
∂t
+ div (j) = ±s (1)
where s is the sink term which represents here the adsorption
of  the permeating solute.
As the model is  being developed for the steady state con-
dition, the time derivative of the solute concentration is nil
here.  Besides, analyzing the geometry of the model one may
distinguish two types of regions depending on the possible
toxin  removal mechanisms: ones with convection and diffu-
sion  only (parts 1, 2 and 4  in Fig. 1), and one layer where,
in  addition to these two mechanisms, adsorption also takes
place  (part 3  in Fig. 1). At steady state and for Cartesian coor-
dinates,  the total molar flux, j,  in the region without adsorbent
Fig. 2  – Schematic representation of formulated system
with  the key parameters for the different layers represented
in Fig. 1.
(s =  0) is constant (Eq. (1)) and has a  diffusive and an advective
contributions (Eq. (2)):
j  = −D
dc
dx
+  Jc  (2)
where c is the local solute concentration gradient, x is the dis-
tance  along the direction normal to  the membrane surface, D
is diffusion coefficient, and J  is convective flow through the
membrane.
If  assuming a  given concentration at the inlet and the out-
let,  the integration of Eq. (2) gives the mass flux across the
regions of the system without adsorptive particles.
j = J
(
c2 − c1e
Jı
D
)
1 − e
Jı
D
(3)
where c2 and c1 stand for the concentrations at the outlet and
the  inlet of the particular region of thickness ı  (Fig. 2).
The application of Eq. (1) to the MMM layer results in  a
differential equation (Eq. (4)), which apart from diffusive and
convective terms, also accounts for the presence of solute
adsorption:
D
d2c
dx2
−  J
dc
dx
−  akc = 0  (4)
where a stands for specific surface area of adsorbent in
m2 per m3 of mixed matrix membrane and k is heterogenic
adsorption constant. The Eq. (4) is integrated through the
MMM  layer by  considering as boundary conditions fixed con-
centration, c2 and c3 at the inlet and the outlet of the layers
respectively (Fig. 2). The details of the integration are pre-
sented  in the Supplementary information 1. It results in Eq.
(5),  which describes the solute concentration at any depth (x)
inside the  MMM layer:
c = c3
e
(
Pe3
2
(
x
ı3
−1
))
sinh
(
x1
ı3
)
sinh (1)
− c2
e
Pe3
2
x
ı3 sinh
(
1
(
x
ı3
− 1
))
sinh (1)
(5)
where 1 =
√
Pe2
3
+4ϕ2
2 ; Pe3 =
Jı3
D3
; ϕ =
√
ak
D3
ı3.Pe3 is the Peclet
number (ratio of advection over diffusion) in the MMM layer
(part  3 in Fig. 1) and ϕ is the Thiele modulus representing the
ratio  of the reaction on the diffusion rate inside the MMM layer.
The  molar flux before the MMM layer (jb), and after (ja) are
determined by  writing the molar flux Eq. (2) at the inlet x = 0
and  the outlet x =  ı3 boundaries respectively:
jb =  c2
(
D31cosh (1)
ı3sinh (1)
+
D3Pe3
2ı3
)
− c3
D3e
−
Pe3
2 1
ı3sinh (1)
(6)
ja =  c2
D3e
Pe3
2 1
ı3sinh (1)
− c3
(
D31cosh (1)
ı3sinh (1)
−
D3Pe3
2ı3
)
(7)
Finally, the solute molar flux density before this layer is
greater  than the one after, jb >  ja; the difference being rela-
tive  to the adsorption rate of the permeating species inside
the  MMM. Summarizing the aforementioned model formula-
tion,  the schematic description of the entire system with its
key  parameters (interface concentrations and fluxes) involved
is  presented in Fig. 2.
2.2. Global mass flux  across  the mixed  matrix
membrane
The model is established by considering the continuity of the
molar  flux before and after the MMM layer. The following sys-
tem  of five equations with two unknown molar flux densities
jb and ja, and three unknown concentrations at the interfaces
of domains c1, c2 and c3 has to be solved:


jb = cfK1a −  c1K1b;
jb = c1K2a −  c2K2b;
jb = c2K3a −  c3K3b;
ja = c2K3c − c3K3d;
ja = c3K4a − cdK4b;
(8)
The expressions for each pseudo mass transfer conductance
(Ki,j)  are determined from the writing of the differential molar
balances  presented in  the previous section. The expressions
for  these conductances are given in the Appendix A.
The  solution for the concentration of the permeating
species on the interfaces adjacent to the adsorptive layer c2
and c3 are given below:
c2 =
K1aK2a (K4a +  K3d) cf +  K3bK4d (K2a +  K1b) cd
(K3a (K2a +  K1b)+  K1bK2b) (K4a +  K3d)−  K3b (K2a +  K1b)K3c
(9)
c3 =
K1aK2aK3ccf + (K3a (K2a +  K1b)+  K1bK2b)K4dcd
(K3a (K2a +  K1b)+  K1bK2b) (K4a +  K3d)−  K3cK3b (K2a +  K1b)
(10)
Combining these last two expressions with Eq. (6) and Eq. (7),
enables determining the molar flux uphill and downhill the
MMM layer.
The  properties of the layers (solute diffusion coefficients
and thickness) and the operating conditions (rate of convective
flow,  adsorption constant and solute concentration on both
sides  of a membrane) provide the possibility to analyze the
transfer through the system at a particular time of the dialysis
process.
Furthermore, the model enables analyzing the impact of
the  adsorptive particles on the local solute concentration
inside the MMM. The transfer efficiency can be compared with
the  pure diffusion case for different scenarios such as: (a)
absence of convection (solute removal occurs only by diffu-
sion  and adsorption); (b) absence of adsorption (presence of
diffusion  and convection), and (c) absence of both convection
and  adsorption. The benefit of the functionalized membrane
compared to a conventional single layer membrane of same
thickness can be  defined through a  solute transport enhance-
ment  factor (STEF):
STEF =
jb
jdiff
(11)
In practice, STEF is defined as a  ratio of molar flux density
(jb)  obtained in one of the aforementioned scenarios to the
molar flux density obtained when only diffusive transport is
involved (jdiff ).  The diffusive case is  used as a  reference of clas-
sical  dialysis and thus STEF demonstrates the intensification
of  the solute removal due to the contribution of convection
or/and adsorption.
In general, membrane fouling phenomena due to protein
adhesion on the membrane, as well as, other phenomena such
as  blood coagulation and thrombus in  the membrane module
can  also play a  role on the solute transfer when working in
real  conditions with blood. Such phenomena would induce an
additional superficial mass transfer resistance that could be
accounted for in  an improved version of the model. The MMM
are  specifically designed to  minimise these phenomena. The
particle  free membrane layer which is in direct contact with
blood, is made by PES/PVP polymer blend, also used in  the
development of the commercial dialysis membranes and has
very good blood compatibility. In fact, our recent study showed
that  the MMM can achieve superior removal of protein bound
toxins  from human plasma compared to commercial dialysers
without fouling phenomena (Pavlenko et  al.,  2016)
Table 1 – Spinning conditions of the fiber preparation.
Membrane 1 Membrane 2
Inner  layer  pumping flow
(mL/min)
0.4  0.9
Outer layer pumping flow
(mL/min)
1.6  3.2
Bore pumping flow (mL/min) 2.8 2.7
Bore composition Demi water  5 wt%  PVP  in
ultra pure
water
Air gap  (cm) 10 –
Pulling speed (m/min) 3.5 7
Content of PVP in  the  dope
solution  for selective layer
(wt%)
7  10
2.3. Clearance  and dialysis  modelling
The model presented in the previous section helps to deter-
mine  the mass flux for given conditions of concentration
across the membrane. This mass flux defines the clearance
for  a  given time of the dialysis. In order to depict the whole
dialysis  process, the mass flux (Eqs. (6), (8)  and (10)) has to be
solved  together with mass balances on the feed compartment
and on the dialysate compartment. The global (Eqs. (12)  and
(13))  and the partial mass balance (Eqs. (14)  and (15)) for the
feed  and the dialysate side are:
dVf
dt
= −JS (12)
dVd
dt
= JS (13)
d
(
cfVf
)
dt
= −jbS (14)
d (cdVd)
dt
=  jaS (15)
where cf and cd stand for the solute concentration in the feed
and  dialysate, S is the filtration surface area, Vf and Vd are
volumes of feed and dialysate.
If  considering that the transient characteristic time for
the  mass flux establishment is very small compared to the
order  of magnitude of the dialysis time, the model can be
solved  for pseudo steady state conditions (considering a  suc-
cession  of steady state for  the transfer). The integration of
Eqs.  (12)–(15) combined with the mass flux given in the previ-
ous  section enables the determination of the variation of the
solute  concentration in  the blood and the dialysate and then
the  clearance kinetics.
3.  Validation  experiments
3.1.  Membrane  fabrication  and characterization
Double layer mixed matrix membranes were prepared accord-
ing  to a  multistep procedure. For the selective layer, a  polymer
solution was prepared by dissolving 15% polyethersulfone
(PES, Ultrason E  6020, BASF, Germany) and polyvinylpyrroli-
done (PVP, K90, Fluka, Germany) of different quantity (details
in  Table 1) in  ultra-pure N-methylpyrrolidone (NMP, Acros
Organics, Belgium). Adsorptive layer was based on a solution
containing 14% PES and 1.4% PVP dissolved in NMP. Activated
Table 2 – Spinneret specifications.
Membrane 1  Membrane 2
Inner diameter  needle (mm) 0.16  0.26
Outer diameter needle  (mm) 0.26  0.46
Inner diameter  first orifice  (mm) 0.46  0.66
Outer diameter first  orifice (mm) 0.66  0.96
Inner diameter  second orifice (mm) 0.86  1.66
Table 3 – Uremic toxins.
Type Specific properties Main representatives
Unbound small  <500  Da Urea,  creatinine
Unbound middle 500  Da–60 kDa Leptin, endothelin,
b2-microglobulin
Protein bound Capable  of protein
binding
Indoxyl sulfate, p-cresol
Table 4 – Characteristics of b2-microglobulin and
a-lactalbumin.
Protein Molecular weight, kDa pI
b2-Microglobulin 11.8  5.7
a-Lactalbumin 14.2  4.5
carbon (AC) with average diameter of 27 mm was added gradu-
ally  to the polymer solution to obtain a final concentration of
60%  by weight. Both solutions were degassed for 48 h before
the  spinning.
Two different spinning conditions were utilized aiming to
obtain  membranes of different transport properties. The first
batch  of membranes (further denoted as Membrane 1) was
formed via immersion precipitation method at the condi-
tions  summarized in Table 1.  The second batch of membranes
(hereon denoted as Membrane 2) was fabricated according to
the procedure described by Tijink et al. (2013) with the condi-
tions,  which are also presented in Table 1.
Table 2 describes the specification of used spinnerets.
The membranes were cleaned by ultra-pure water to
remove the remaining solvent. The fibers were then dried at
37 ◦C  for 2 h and subsequently were fractured in liquid nitro-
gen.  The samples were dried under vacuum at 30 ◦C and gold
sputtered using a Balzers Union SCD 0 40 sputter coater (Oer-
likon  Balzers, Balzers, Liechtenstein). Finally, samples were
imaged using a  JEOL JSM-560 0LV Scanning Electron Micro-
scope  (JEOL, Tokyo, Japan).
Dry  fibers were cut into pieces of  15 cm each and then glued
into  modules (inner diameter of 4 mm) of 3 fibers each, and
10  cm in length. Clean-water flux was then measured for each
module  with use of the set-up (Fig. 3 from Pavlenko et al., 2016)
described  in detail in the following section. For this, modules
were initially pre-pressurized at 2 bar for 1 h and then tested
at  transmembrane pressures of 0.5, 1.0, 1.5 and 2.0 bar, with
ultrapure water. The mass of collected permeate was moni-
tored continuously.
3.2.  Adsorption  kinetics  in  static  mode
At  this stage, the knowledge of the adsorptive capacity of the
carbon  particles is  an important issue. Experiments were con-
ducted  to determine the kinetics of adsorption of creatinine
and  a-lactalbumin onto the membrane. These two solutes
have been chosen as models to  illustrate the potentialities and
the  limitation of mixed matrix membranes in the removal of
unbound  small and middle uremic toxins (Table 3).
Fig. 3  – Schematic representation of the applied set-up (from Pavlenko et  al., 2016).
Creatinine  was selected as a  model of unbound small
toxins  group when a-lactabumin was selected as a model
compound for unbound middle-sized toxins such as b2-
microglobulin. Similarities between the molecular weight
and  the Isoelectric point of both proteins justify this choice
(Table 4).
For the purpose of kinetics of adsorption study, five pieces
of  hollow-fiber membranes of 5 cm each were placed in 25 mL
of  0.1 g/L solution of creatinine or a-lactalbumin in phosphate
buffer solution (PBS). The solution was stirred to avoid trans-
port  limitations between solute and surface of adsorptive layer
of the membrane. The decay of solute concentration with time
was monitored by sampling of 0.5 mL/sample every 3 min for
further analysis by UV-spectroscopy. The timing of sample col-
lection was adjusted so as to limit the total withdrawal of
initial  volume at 10%. A linear decrease of the solute con-
centration in the initial stage of the process was observed.
The initial slope of the concentration decrease provides an
information on the rate of adsorption which may be used in
the  calculation of the product of the adsorption constant and
specific  surface area of adsorbent (ak).
3.3. Experimental  study  of the clearance  of small  and
middle sized  solutes
The experimental analysis of the clearance of solutes with the
dual-layer membranes was conducted with use of the set-up
(Convergence B.V., Enschede, The Netherlands) presented on
Fig.  3.
Briefly, the experimental set-up consists of  2 peristaltic
pumps, 4  pressure detectors, 2 back-pressure valves and 2
reservoirs  for the model solutions (Pavlenko et  al.,  2016). All
the  parts of the set-up are connected via PTFE tubings to mem-
brane module which has inlets and outlets for the feed and
dialysate solutions that are pumped in counter-current con-
figuration.  The flow rates of the feed and dialysate solutions
are  controled by the peristaltic pumps, while constant TMP is
generated by the back-pressure valves. Pressure in the system
is  monitored by 4 pressure detectors which are located near
the  membrane module’s inlets and outlets. Compartments for
the module solutions are positioned on the balances to control
the  mass of the system over time.
For the validation experiment, PBS-based 0.1 g/L solutions
of  creatinine (Sigma–Aldrich, France) as a model molecule for
the  small uremic toxin; and a-lactalbumin (Sigma–Aldrich,
France) as  a model compound for the middle-sized molecule
were prepared, and were further used as feed solutions. The
pure  solution of PBS was used as the dialysate.
Validation experiments were conducted using 50 mL of
the  feed and dialysate solutions. Moreover, we followed the
convention that the flow rate of the dialysate has  to be
twice  as high as the flow rate of the feed stream (Henrich,
2009).  As such, the feed flow rate was set  as 5 mL/min, while
the  dialysate flow was equal to 10 mL/min. In addition, the
feed solution was flown inside the hollow fiber membrane
lumen, while the dialysate was pumped through the shell side
of  the module. For experiments in  diffusive mode (conven-
tional  dialysis), the transmembrane pressure (TMP) was kept
around  0 bar, meaning that the toxin removal driving force was
generated only by the difference of its concentration across
the  membrane. In contrary, another set of experiments was
conducted with utilization of both diffusion and convection
(hemodiafiltration mode). There the TMP was set  at 0.17 bar  or
0.5 bar in different experiments in order to induce the convec-
tive  transport through the membrane. These pressure regimes
were  chosen in order to, on one hand, avoid the necessity to
add  more feed to the system during the experiment, and on
the  other hand, to generate a convective flow with a  notice-
able  impact on the overall solute removal. Throughout the
experiment, the weight of the feed and dialysate solutions was
continuously monitored. The decrease of the feed (increase of
the  dialysate) mass was considered to be due to the presence
of  convection. Samples of 1 mL were taken from both compart-
ments  at the same time and the concentration of creatinine
and  a-lactalbumin was measured by UV-spectroscopy (Var-
ian,  Cary 300 Scan UV–visible Spectrophotometer) at 25 ◦C in a
10 mm quartz cuvette at 230 nm and 280 nm, respectively. The
increase  in  solute concentration in  the dialysate was ascribed
to  the diffusive transport, in case of the experiment conducted
in  diffusive mode (conventional dialysis) or to a  combina-
tion of diffusion and convection for experiments performed
in  hemodiafiltration mode. In parallel, based on mismatch
between the amount of solute disappeared from the feed side
and  found in the dialysate the quantity of solute adsorbed
Fig. 4  – SEM images of the dual-layer MMM (Membrane 2: -a- and -b-; Membrane 1: -c-, -d- and -e-).
inside  the membrane was defined. Finally, the total solute
removal  was considered to be the sum of diffusive/convective
and adsorptive removals. Each validation experiment was
conducted three times. After the  experiments, the modules
were  dried in  air and the effective surface area of membrane
inside  the module was measured.
4.  Results  and  discussion
4.1.  Membrane  fabrication  and characterization
Fig. 4 demonstrates the structure and the morphology of the
membranes.
Fig.  4 compares the images of the Membrane 2 (Fig. 4 a,b)
and  Membrane 1 (Fig. 4 c–e) discussed in this study. For both
membranes, one can distinguish the inner particle-free region
with  a  denser skin layer on the lumen side and the outer
particle-loaded (MMM) layer. In both cases, the two layers
are well attached, the MMM layer is more porous and the
particle-free inner selective layer, mainly determines to the
Table 5 – Geometrical dimensions of the fabricated
fibers.
Membrane 1  Membrane 2
Thickness of the  inner layer, mm 21  49
Thickness of MMM,  mm  47  111
Lumen diameter, mm 450  669
External diameter of the fiber, mm  586  984
mass transport resistance of the entire membrane. For the
Membrane 1, the particle free inner has a dense skin (see
Fig.  4-e-) and a  rather finger like pore morphology towards
the MMM layer. For the Membrane 2,  the inner particle free
layer has overall sponge like morphology and is less dense (see
Fig.  4-b-). For both membranes 1 and 2, SEM images suggest
that  the activated carbon particles are quite uniformly dis-
tributed inside the polymeric matrix. In general, Membrane
1 is much thinner than Membrane 2.  The dimensions of the
fibers are summarized in Table 5. These values were further
Table 6 – Values of reaction kinetic parameter, ak, for
various systems “Membrane-solute”.
Membrane 1 Membrane 2
Creatinine 0.152 s−1 0.082 s−1
a-Lactalbumin –a 0.011 s−1
a Was  not  determined, because Membrane  1 was impermeable for
a-lactalbumin.
used for simulations based on the mass transfer model, which
has  been described here above.
The clean water flux tests revealed that the Membrane 1
is  significantly less permeable than M2: 2.5 ± 1.1 L/m2/h/bar
vs  58.4 ± 9.3 L/m2/h/bar (Tijink et al.,  2013) respectively, con-
sistent  with the SEM observations. The integrity of the
membranes was not affected during the water permeance
testing, meaning that the fabricated membranes possess
sufficient mechanical strength for the dialysis and hemodi-
afiltration experiments.
The  product of heterogeneous adsorption constant and
specific surface area of activated carbon (ak) is refered to
as  a reaction kinetic parameter hereafter, for both mem-
brane types was determined with respect to creatinine and
a-lactalbumin (Table 6).
According to Table 6,  the reaction kinetic parameter, ak,
parameter for the adsorption of creatinine is almost twice
higher  for Membrane 1 than  for Membrane 2. Since the mem-
brane material and the adsorptive particles are the same
for  both membranes, the difference in adsorptive properties
between these membranes may be attributed to  the differ-
ent  accessibility of activated carbon particles embedded in
the  polymer matrix. In  parallel, the comparison of adsorptive
properties of Membrane 2 with respect to creatinine and a-
lactalbumin demonstrates that the adsorption of the latter
is  significantly lower than the  former (only 0.011 s−1).  This
may  be attributed to either a difference in steric hindrance
or  connected to the different affinity of activated carbon
particles for creatinine and a-lactalbumin. Finally, various per-
meation  trials with Membrane 1 revealed that it is completely
impermeable for a-lactalbumin; therefore, the experimental
estimation of “ak” for this case was not performed.
4.2. Double layer membrane  transfer  modeling
To perform the modelling of the transfer through the MMM,
the  boundary layer thicknesses (ı) have to  be estimated.
Since the validation of the model was performed with  the
hollow-fiber membranes placed in the module, two sets of
hydrodynamic correlations, for lumen and shell sides, were
used.  The flow rates of feed and dialysate streams were taken
from  the filtration the set-up utilized during the validation
experiments. The estimation of the conditions in the lumen
side  was done using two following correlations (Yang et  al.,
2013):
Shl = 2.66Re
0.25
l Sc
0.33
l
(
dhl
l
)0.33
; ıl =
dhl
Shl
(16)
while the quantification of the hydrodynamic conditions in
the  shell side was done by applying another set of equations
(Yang et al., 2013):
Shs = 1.25Re
0.93
s Sc
0.33
s
(
dhs
l
)0.93
; dhs =
(
d2s −  Nd
2
e
)
(ds + Nde)
; ıs =
dhs
Shs
(17)
where dh stands for the hydraulic diameter, N is  the number
of  fibers, de and ds are the external diameter of the mem-
brane and of the module (shell) respectively. The selected
correlations are assumed to be applicable, as they were devel-
oped  for hollow fiber modules operated in laminar conditions
(R  < 2000), while in  our experiments Re in the shell and the
lumen  side was below 100.
The validation experiments were conducted using feed and
dialysate flow rates of 5 mL/min and 10 mL/min, respectively.
Since  a  low concentration of solute was used for the prepa-
ration  of all feed solutions and the pure phosphate buffer
was  used as the dialysate, the viscosity and density of both
solutions were assumed to be equal to the ones of water:
10−3 Pa s and 1000 kg/m3 respectively for the calculation of
the  boundary layer thicknesses. Based on the aforementioned
hydrodynamic correlations, the thicknesses of the boundary
layers  in the lumen and shell sides were determined (Table 7).
The  boundary layer thickness in  the creatinine removal
experiments differs in case of Membrane 1 and Membrane
2.  This difference is ascribed to the difference in mem-
brane dimensions (see Section 4.1). Similarly, due to  the
difference between the outer diameters of both membranes,
the boundary layer thickness on the shell side was found
smaller  for Membrane 1. Similar conclusions are found for the
a-lactalbumin removal experiments. The lumen boundary lay-
ers  were found to be 17.9 mm and 23.8 mm, while the shell side
boundary layers are 87.1 mm and 124 mm for Membrane 1 and
Membrane 2, respectively.
According to  data presented by Shaw et al. (2009) the diffu-
sion  coefficient of creatinine in  water at  room temperature
is  9 × 10−10m2/s,  while Kim et al. (2013) used the value of
5.31  × 10−10m2/s. Therefore, here we used the average value
of  7 × 10−10m2/s. To the  best of our knowledge, the diffusion
coefficient of a-lactalbumin was not reported in the literature.
Thus with use of Einstein equation and molecule effective
radius reported by Fu et al. (2005) it was calculated to be
equal  to 1.07 × 10−10m2/s. Finally, for the sake of simplicity
we assumed that the solute diffusion coefficient is the same
in  the all regions of the system.
Table 7 – Boundary layer thicknesses in the validation experiments.
Membrane 1  Membrane 2
Experiment with
creatinine
Lumen  boundary layer, mm 30.7  45.3
Shell side boundary layer,  mm 197  245
Experiment with
a-lactalbumin
Lumen  boundary layer, mm 17.9  23.8
Shell side boundary layer,  mm 87.1  124
Fig. 5 – Solute concentration profiles across the membrane depending on the removal mechanisms involved. (BBL stands for
blood boundary layer, PFL — particle free layer, MMM — mixed matrix membrane) (Image A — diffusion vs
diffusion  + adsorpsion; image B  — diffusion +  convection vs diffusion + convection +  adsorption).
Table 8 – Input parameters applied to produce creatinine
concentration profile across Membrane 2.
Name of input parameter Value
Blood boundary layer thickness 5 ×  10−5m
Particle-free layer thickness 4.9 ×  10−5m
MMM thickness 1.11  × 10−4m
ak parameter 0.082  s−1
Solute  diffusion coefficient 7 ×  10−10m2/s
Thickness  of dialysate boundary layer 2.3 ×  10−4m
Convective flow rate through  the membrane 1.1 ×  10−6m/sa
Solute  concentration in  the blood side 0.885  mol/m3
Sieving coefficient 1
a Experimentally measured average convective flow rate over the
filtration process.
The parameters used for our simulations have been gath-
ered  in  Table 8. In principle, these parameters represent the
filtration  of creatinine through the Membrane 2.
The predicted solute concentration profiles across the
membrane with and without adsorption have been plotted in
Fig.  5, in the absence of solute in the dialysate stream.
According to  Fig. 5 the presence of adsorptive particles
favors the reduction of solute concentration inside the mem-
brane.  The molar flux of solute through the membrane is then
more  important: one can note a  steeper concentration profile
in  the blood boundary layer (BBL). This effect is attributed to
the  adsorption of a  fraction of the permeating species by the
particles  present in the MMM that is accelerating the mass
transfer. Quantitative expression of such phenomena is given
by  the solute transfer enhancement factor (STEF) parameter
provided by the model (Table 9).
From Table 9  one may conclude that for the selected set
of  input parameters, the addition of convective flow to  solely
diffusion-driven solute removal results in a 1.39 times greater
Fig. 6  – Solute concentration profile across the membrane
and feed boundary layer at various rates of convective
flows.
removal rate, while adsorption provides a  STEF of 2.21. More-
over,  the combination of all three removal mechanisms is
characterized by a  STEF of 2.58, meaning that compared to
a  pure diffusive transfer, the complete system allows to gain
more  than 2.5 times a flow of solute out of the feed (blood).
In  parallel, the concentration inside the membrane as well
as  the molar flux across the membrane depend on hydro-
dynamics on the feed side. Fig. 6 shows the influence of
convection flow rate (Peclet number) on the system, where dif-
fusion, convection and adsorption are employed in the solute
removal from the feed stream.
As it can be seen in Fig. 6, at lower values of Pe the
solute concentration in the  MMM is  significantly different
from the one in the bulk. However, at Pe  > 1, when convection
becomes dominant over diffusion, the solute is more effi-
Table 9 – Solute transfer acceleration for various system conditions.
Solute removal mechanisms involved Molar flux density, ja Solute transfer
enhancement  factor
Diffusion 1.41  ×  10−6mol  m−2 s−1 1a
Diffusion  and adsorption 3.12  ×  10−6mol  m−2 s−1 2.21
Diffusion  and convection 1.95  ×  10−6mol  m−2 s−1 1.39
Diffusion,  convection, and  adsorption 3.63  ×  10−6mol  m−2 s−1 2.58
a Taken  as reference.
Fig. 7 – Results of validation experiment 1  vs theoretical
prediction (continuous lines are predicted evolution of
solute  removal, while dots represent the experimental
results).
ciently transferred towards the adsorptive layer, and the bulk
and  membrane concentrations are close to each other. In order
to  keep a Pe larger than 1, the convective flow of 1.4  × 10−5m/s
or  greater has to be generated. On the other hand, an exces-
sive  convection rate leads to the reduced impact of adsorption
on  the solute removal. Therefore, at high Pe one does not take
advantage of the presence of the adsorptive capacity of the
membrane.
4.3. Experimental  results  vs  modelling
A first experiment was conducted in the diffusive mode with
use  of creatinine solution and Membrane 1. The experimental
results are compared to  the model in Fig. 7.
According to Fig. 7 the diffusive curve is ideally predicting
the  removal of creatinine by diffusion. Both experimental and
theoretical  results demonstrate that during a four-hour exper-
iment  at given conditions, one may achieve diffusive removal
of  0.6 mg of creatinine in our conditions. The slight deviation
of  diffusive curve from linearity is a result of decrease in solute
concentration in  the feed and increase in the dialysate, which
leads  to the reduction of the driving force across the mem-
brane.  In contrary, the adsorption curve fits the experimental
data only in the early stage of the process. This observation
may be explained by the saturation of adsorptive particles,
which  suggests the presence of limiting membrane adsorption
capacity. In our experiment this effect starts to  be noticeable
after  half an hour of experiment and ultimately reaching a
membrane  adsorptive capacity of 0.34 mg or, more precisely,
26.27  mg of creatinine per 1 mg of membrane. Therefore, a
modification of the model with the new fitted input parame-
ter  “Membrane limiting adsorption capacity” (MLAC) was done
aiming to account for the activated carbon particles saturation
(Fig.  8). In order to introduce this parameter in the model, the
following conditions were applied:
{
q  < qmax, r = akc
q ≥ qmax, r = 0
(18)
Hence until the amount of adsorbed species (q) is inferior
to  the maximal capacity (qmax),  the adsorption mechanism
is  active and is happening according to the previously dis-
cussed assumptions. Once the maximal membrane capacity
Fig. 8  – Results of  validation experiment 1 vs theoretical
prediction accounting saturation of the adsorbent.
has been reached, the adsorption is no longer possible and
therefore, the adsorptive removal mechanism is switched off
by the model. The result of MLAC application for the experi-
ment  1 is presented in Fig. 8.
According to Fig. 8, the removal of creatinine reaches a
plateau. This could be due to saturation of particles and/or
limitations in accessibility of the carbon adsorption sites by
the  solute under diffusive conditions. In fact, our recent work
has  showed that under convective conditions the adsorption
and  removal can significantly increase (Tijink et al., 2013)
The  insertion of the limiting adsorption capacity parame-
ter  enables a  rather precise prediction of the outcome of the
experimental creatinine removal. Finally, the analysis showed
that  the adsorptive particles in  the membrane enhance the
transfer of creatinine by 93% within the first 45 min. Such
observation provides the numerical justification of the benefi-
cial  use of dual-layer membranes with incorporated particles
of  activated carbon.
A  validation experiment with use of creatinine solution and
Membrane 1 was also conducted in hemodiafiltration mode
(applying TMP). However, due to tight structure of the skin-
layer  in  the particle free membrane the convection was limited
even  at high pressures, therefore the convective term had a
negligible contribution to mass transfer during the experi-
ment.  Consequently, the result of this experiment was almost
identical  to the one with diffusive transport only (results not
shown).
In  addition, due to poor permeability of a-lactalbumin
through Membrane 1 and its poor diffusivity through Mem-
brane  2 during the diffusive experiment, no noticeable
concentration reduction in the feed side was observed. There-
fore,  the results of these trials are also not presented in this
paper as well.
In  order to evaluate the validity of the model with respect
to  middle sized solutes, a second experiment was conducted
with Membrane 2 and a-lactalbumin at TMP of 0.5 bar, result-
ing  in the convective flow of 3.38 × 10−6m/s. The results of
the  second experiment and their comparison with the model
predictions model are shown in  Fig. 9.
As shown in  Fig. 9, the experimental and computed data
for  the diffusive+convective removal of a-lactalbumin are in
very  good agreement. Thanks to a significant convection rate,
the  removal of 2 mg of a-lactalbumin was achieved within four
hours  in our experimental conditions. In addition, the adsorp-
tive  removal of 0.47 mg was observed after half an hour, and
did  not change throughout the remaining time. This observa-
Fig. 9 – Results of validation experiment 2 vs theoretical
prediction.
tion indicates that, alike the first experiment, the saturation of
adsorptive  particles was achieved within the early stage of the
process.  The fast saturation may be attributed to the presence
of  convection, which enabled facilitated transport of protein
towards  the activated carbon particles. This hypothesis was
supported by  the analysis, which demonstrated that since
convection is much faster than diffusion of a-lactalbumin, it
provided  8.4 times solute transport enhancement in the begin-
ning  of the process. In the same time, the presence of the
adsorptive layer resulted in 71% of protein removal facilita-
tion.  Finally, the cumulative effect of MMM and convection
enabled 9.4 times greater solute removal rate at the initial
moment  of the experiment (t = 0) than one may expect from
solely  diffusion-based process given the experimental condi-
tions  used in the present research.
Since during experiment 2 the saturation of the MMM was
achieved, we modified the model with the “Membrane limiting
adsorption capacity” parameter as before. Based on the exper-
imental result the input value of 8.1  mg of a-lactalbumin per
mg  of membrane was taken. In  addition, the content of acti-
vated  carbon inside Membrane 2 was previously reported to
be 53% (Tijink et al., 2012). Therefore, the MLAC value may be
also  presented as 15.2 mg of a-lactalbumin per mg of activated
carbon inside the membrane. This value is close to the exper-
imentally measured adsorptive capacity of activated carbon
powder of 15.9 mg of a-lactalbumin per mg of activated carbon.
The  comparison between validation experiment 2 and
modified model is shown in Fig. 10.
According to Fig. 10, the saturation of the adsorbent was
reached after 30 min of experiment, and the remaining time, a-
lactalbumin was removed from the feed mainly by convection
and  partially by diffusion.
Thus  the model reveals that the MMM layer  is efficient in
the  early stages of the process, significantly increasing the rate
of removal. Beyond that point, corresponding to  the saturation
of  the adsorbents, the rate of removal is ruled by the diffusion
and  convection as for a classical hemodiafiltration process.
Obtained MLAC value for Membrane 2 may be  viewed from
a  different perspective. The module consisting of 3 fibers
of  10 cm each and lumen diameter of 669 mm (Table 5)  pro-
vided  the total filtration area of 0.567 × 10−3m2, allowed an
adsorptive removal of  0.47 mg of a-lactalbumin. Considering
the common hemodialyser with an effective surface area of
1.5  m2, the  proportional scale-up of our module would result
in  1242 mg removal of a-lactalbumin, which significantly
Fig. 10 – Results of validation experiment 2 vs theoretical
prediction accounting saturation of the adsorbent.
exceeds the desired b2-microglobulin removal of 350–700 mg
per  session (based on thrice weekly treatment) (Drueke and
Massy, 2009). As such, even without further optimization
(reduction of lumen diameter, tuning of sieving properties,
selection of proper operating conditions etc), this membrane
may be effectively used for the removal middle-sized uremic
toxins.
5.  Conclusion
The concept of double layer membranes aiming the improve-
ment  of removal of blood toxins is a promising advancement
of  dialysis treatment. In the present study, we presented the
model  which allows more in-depth analysis of interplay of
three  solute removal mechanisms: diffusion, convection, and
adsorption. The model demonstrated the solute concentra-
tion profile across the membrane and quantified the transfer
improvement induced by the adsorption layer inside the mem-
brane.  The model was validated via comparison of model
predictions with outcome of experimental testing of home-
made double layer mixed matrix membranes. The developed
model  provides an accurate agreement with diffusive and
convective removals obtained experimentally for both small
and  middle sized uremic toxins. Moreover, even a  rather sim-
plistic  approach in the modelling of adsorptive removal of
toxins  (first-order reaction) provides a possibility to evaluate
the  amount of adsorbed species at the early stages of treat-
ment  process. The developed model may be further applied
in  the optimization of double layer membrane properties and
the  process conditions.
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Appendix  A.
The complete expressions for  pseudo mass transfer conduc-
tances  (Ki,j),  which are used in Section 2.2, have the following
form:
K1a =
JePe1
ePe1 − 1
(A.1)
K1b =
J
ePe1 − 1
;  (A.2)
K2a =
JePe2
ePe2 − 1
; (A.3)
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(A.8)
K4a =
JePe4
ePe4 − 1
; (A.9)
K4b =
J
ePe4 − 1
(A.10)
Appendix  B.  Supplementary  data
Supplementary data associated with this arti-
cle can be found, in the online version, at
http://dx.doi.org/10.1016/j.cherd.2017.08.017.
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